Consumer Products
Personal Care
Biopharmaceutical

Veru

$1.89
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-2.07%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Veru and other stocks, options, ETFs, and crypto commission-free!

About VERU

Veru Inc. Common Stock, also called Veru, is a urology and oncology biopharmaceutical company, which engages in the development, manufacture and marketing of consumer health care products. Read More It operates through the Commercial; and Research and Development segments. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. The company was founded by William R. Gargiulo Jr. and O.B. Parrish in 1971 and is headquartered in Miami, FL.

Employees
171
Headquarters
Miami, Florida
Founded
1971
Market Cap
122.92M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
271.84K
High Today
$1.96
Low Today
$1.87
Open Price
$1.93
Volume
166.80K
52 Week High
$2.49
52 Week Low
$1.18

Collections

Consumer Products
Personal Care
Biopharmaceutical
Advertising and Marketing
Healthcare
Research And Development
Retail
Pharmaceutical

VERU News

ReutersAug 9

Edited Transcript of FHCO earnings conference call or presentation 8-Aug-19 12:00pm GMT

23
BenzingaJul 31

Biotech Stock On The Radar: Veru, A Catalyst-Rich Biopharma

132

VERU Earnings

-$0.15
-$0.11
-$0.07
-$0.03
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
-$0.04 per share
Actual
-$0.04 per share

More VERU News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.